Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

PRP shows promise for hair loss treatment, with three initial monthly injections and maintenance every 3-6 months.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

Nanotechnology improves hair care products by enhancing ingredient stability, targeting treatment, and reducing side effects, but more research on its toxicity is needed.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Dutasteride-containing mesotherapy effectively treats female hair loss, improving density and thickness with minimal side effects.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

Antimicrobial lotion reduces inflammation and increases hair density in hair loss patients.

Androgens may block hair growth signals, targeting this could treat hair loss.

Herbal extracts and platelet-rich plasma together may help increase hair growth by making certain cells grow more, through specific cell growth pathways.

SCF and c-Kit decrease in AGA hair follicles, possibly affecting hair pigmentation and growth.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Men's hair loss is caused by hormones and genes, and can be treated with medication and surgery, while graying is due to aging and has no prevention except dyeing.

Aging alone rarely causes significant hair loss; hormones are a bigger factor.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

Women with PCOS tend to have higher anxiety and depression levels compared to healthy women.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

Minoxidil effectively treats female pattern hair loss.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

Pregnant women's hair gets thicker.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.